Minerva Surgical to Announce First Quarter 2023 Financial Results

Rhea-AI Summary

Minerva Surgical, Inc. (Nasdaq: UTRS) announced it will release its first quarter 2023 financial results on May 2, 2023. The announcement comes with a scheduled conference call and webcast at 1:30 p.m. Pacific Time to discuss the financial outcomes and recent developments. The company focuses on developing minimally invasive solutions for uterine healthcare, specifically addressing Abnormal Uterine Bleeding (AUB) while aiming to eliminate unnecessary hysterectomies. Minerva Surgical's product line is commercially available and aims to cater to various uterine anatomies, meeting the distinct needs of women's healthcare.

Positive

• Minerva Surgical plans to release first quarter 2023 financial results, suggesting potential for relevant updates on financial health and business performance.
• The company focuses on innovative solutions for uterine healthcare, indicating a potential for growth in a specialized industry.

Negative

• None.

SANTA CLARA, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a medical technology company focused on solutions to meet the distinct uterine healthcare needs of women, announced today that it will release its first quarter 2023 financial results on Tuesday, May 2, 2023. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that should be used to join the call.

The live webinar of the call may be accessed by visiting the Recent Events section of the company’s website at http://ir.minervasurgical.com. A replay of the webinar will be available on the Company’s website shortly after the conclusion of the call.

About Minerva Surgical, Inc.

Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

INVESTOR RELATIONS CONTACT

Caroline Corner
investors@minervasurgical.com
415-202-5678

RELATED LINKS

https://www.aubandme.com

https://www.minervasurgical.com

FAQ

When will Minerva Surgical release its first quarter 2023 financial results?

Minerva Surgical will release its first quarter 2023 financial results on May 2, 2023.

What time is the Minerva Surgical conference call on May 2, 2023?

The conference call will be held at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I access the Minerva Surgical Q1 2023 financial results call?

You can access the call by registering via the link provided in the press release or by visiting the company's website.

What is the focus of Minerva Surgical's products?

Minerva Surgical specializes in minimally invasive solutions for uterine healthcare, targeting issues such as Abnormal Uterine Bleeding.